The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Tournis, Symeon  [Clear All Filters]
Journal Article
Polyzos, S. A., Tournis S., Goulas A., Kollia P., & Whyte M. P. (2021).  Adult hypophosphatasia treated with reduced frequency of teriparatide dosing.. J Musculoskelet Neuronal Interact. 21(4), 584-589.
Yavropoulou, M. P., Vaios V., Pikilidou M., Chryssogonidis I., Sachinidou M., Tournis S., et al. (2017).  Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.. J Clin Densitom. 20(4), 490-497.
Yavropoulou, M. P., Poulios C., Foroulis C., Tournis S., Hytiroglou P., Kotsa K., et al. (2018).  Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor.. Endocrinol Diabetes Metab Case Rep. 2018,
Anastasilakis, A. D., Polyzos S. A., Makras P., Trovas G., Yavropoulou M. P., & Tournis S. (2021).  Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation.. J Clin Densitom.
Tournis, S., Yavropoulou M. P., Polyzos S. A., & Doulgeraki A. (2021).  Hypophosphatasia.. J Clin Med. 10(23), 
Anastasilakis, A. D., Tournis S., Yavropoulou M. P., Polyzos S. A., & Makras P. (2018).  Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?. Calcif Tissue Int. 103(1), 107-108.
Polyzos, S. A., Makras P., Tournis S., & Anastasilakis A. D. (2019).  Off-label uses of denosumab in metabolic bone diseases.. Bone. 129, 115048.
Anastasilakis, A. D., Trovas G., Balanika A., Polyzos S. A., Makras P., & Tournis S. (2020).  Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough.. J Clin Densitom.
Yavropoulou, M. P., Gerothanasi N., Frydas A., Triantafyllou E., Poulios C., Hytiroglou P., et al. (2015).  Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors.. Endocrinol Diabetes Metab Case Rep. 2015, 150025.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.